On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration for its insulin pump system is near.
After a pause under the Saving on a Valuable Education (SAVE) program, the U.S. Department of Education is resuming student ...
The drug, called Rybelsus, is the only oral GLP-1 medication available. It was previously approved to treat Type 2 diabetes ...
The Trends in Travel™. The annual global report highlights shifts in traveller behavior and the destinations set to dominate ...
In its latest pivot, Verily is introducing a consumer app that will offer users free health guidance from clinicians. the ...
Joel O’Leary is a full-time Personal Finance Writer at Motley Fool Money, covering credit cards, bank accounts, investing, mortgages, and other personal finance topics. Joel has been writing about ...
TipRanks on MSN
HUTCHMED’s FRUSICA-2 Trial Shows Promising Results for Renal Cell Carcinoma Treatment
An update from HUTCHMED (China) ( ($HK:0013) ) is now available. HUTCHMED announced significant results from the FRUSICA-2 registration trial, ...
At the University of Nevada, Reno, we believe in the power of purpose and the strength of the Pack. Whether you're engineering clean energy, studying literature’s role in social change, or designing ...
Through teaching, publishing, convening, fact-checking and media literacy, Poynter creates a crossroads where communities come together to use journalism to confront society’s complex problems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results